{{Rsnum
|rsid=701848
|Gene=PTEN
|Chromosome=10
|position=89726745
|Orientation=plus
|GMAF=0.3416
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 15.3 | 44.1 | 40.5
| HCB | 15.3 | 47.4 | 37.2
| JPT | 18.8 | 45.5 | 35.7
| YRI | 1.4 | 21.8 | 76.9
| ASW | 3.6 | 32.1 | 64.3
| CHB | 15.3 | 47.4 | 37.2
| CHD | 15.7 | 45.4 | 38.9
| GIH | 35.6 | 45.5 | 18.8
| LWK | 1.8 | 11.8 | 86.4
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 6.5 | 93.5
| TSI | 16.7 | 50.0 | 33.3
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19625176
|Title=PTEN identified as important risk factor of chronic obstructive pulmonary disease
|OA=1
}}

{{PMID Auto
|PMID=21138334
|Title=Association of PTEN Polymorphisms with Susceptibility to Hepatocellular Carcinoma in a Chinese Han Population
}}

{{PMID Auto
|PMID=17033968
|Title=Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes.
|OA=1
}}

{{PMID Auto
|PMID=18805939
|Title=Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis.
|OA=1
}}

{{PMID Auto
|PMID=19237173
|Title=Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy.
}}

{{PMID Auto
|PMID=22336889
|Title=Association of genetic polymorphisms in MDM2, PTEN and P53 with risk of esophageal squamous cell carcinoma.
}}

{{PMID Auto
|PMID=23209702
|Title=A Functional Variant in the MTOR Promoter Modulates Its Expression and Is Associated with Renal Cell Cancer Risk
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}